Yuyu Pharma (000220) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Yuyu Pharma (000220) reported revenue of 140.9 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025140.9 billion KRW11.0 billion KRW9.1 billion KRW[source]
2024133.1 billion KRW11.7 billion KRW10.3 billion KRW[source]
2023137.2 billion KRW365 million KRW-5.5 billion KRW[source]
2022138.9 billion KRW-592 million KRW-4.4 billion KRW[source]
2021115.7 billion KRW1.2 billion KRW-920 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025169.5 billion KRW51.9 billion KRW117.6 billion KRW[source]
2024177.1 billion KRW62.1 billion KRW115.0 billion KRW[source]
2023170.5 billion KRW67.7 billion KRW120.4 billion KRW[source]
2022168.9 billion KRW61.2 billion KRW123.4 billion KRW[source]
2021170.2 billion KRW52.3 billion KRW128.7 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
202515.9 billion KRW-12.4 billion KRW-16.5 billion KRW[source]
202425.0 billion KRW-4.0 billion KRW-9.9 billion KRW[source]
2023421 million KRW-2.8 billion KRW7.2 billion KRW[source]
2022-6.2 billion KRW-8.5 billion KRW-9.1 billion KRW[source]
20214.5 billion KRW-5.9 billion KRW31.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice